Vitamin D supplementation beneficial for glucose markers among postmenopausal women

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-08-24 06:00 GMT   |   Update On 2023-08-24 10:57 GMT
Advertisement

The increase in the prevalence of type 2 diabetes is closely linked to the upsurge in obesity. Obesity and associated metabolic syndrome is also linked to impaired glucose tolerance. Epidemiological studies have linked low vitamin D levels to the pathogenesis of diabetes and also supported the favorable effects of adequate vitamin D intake on reducing the risk of T2D.

Dr Hao L et al. and colleagues have recently found in a new study that among postmenopausal women, Vitamin D is beneficial for glucose markers but not obesity.

The  findings of the study have been  published in the Journal  Clinical  Therapeutics.

The effect of vitamin D effect on glucose markers and obesity in postmenopausal women remains controversial. There needs to be more data available on the dosage and duration of vitamin D for optimal efficacy in postmenopausal women. This background was researched in the present study using databases without language restrictions. The data was collected from PubMed/MEDLINE, Web of Science, EMBASE, and Scopus.

A total of Nine eligible articles with 12 comparisons qualified for the final quantitative analysis and the findings could be summarised as follows:

  • An overall decrease was noted in fasting blood glucose, homeostatic model assessment for insulin resistance, insulin and glycosylated haemoglobin with a weighted mean difference of -3.56 mg/dL; -1.168 mm; -2.26 units; and -0.41%, respectively after vitamin D administration in postmenopausal women.
  • In subgroup analyses, there was a notable decrease in fasting blood glucose when the intervention course was ˃6 months and dosage ≤1000 IU/d with WMD, -3.48 mg/dL.
  • Vitamin D was not associated with body mass index, weight, or waist circumference.

The researchers have concluded that Vitamin D is beneficial for glucose markers but not obesity in postmenopausal women.

However a personalized dosage plan for vitamin D should be implemented for postmenopausal women based on the target clinical outcomes.

Further reading:

DOI: https://doi.org/10.1016/j.clinthera.2023.07.009

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News